Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-002161-56Phase 4Completed
Phase 4, single-arm trial of naltrexone in hypersexuality, sponsored by Mateusz Gola. Primary endpoints: Change in Sex Addiction Screening Test (SAST) score, Change in Sexual Arousability Inventory (SAI) score and 2 more. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-002161-56.